MPO and airway hyperresponsiveness: Our in vivo study showed that Nec-1 could alleviate airway hyperresponsiveness in OVA/CFA mouse model (Figure 4A), and also reduced the level of NETs, total protein concentration and MPO activity in BAL as well (Figures 4C–E).